Aggregated price index with volume information
Summary:
- Digital Healthcare stocks up 3.9% on average while median return up 2.1% in a day
- Digital Healthcare stocks up 8.3% on average while median return up 5.7% in a week
- Digital Healthcare stocks down 7.0% on average while median return down 8.1% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are
- 1M losers are : Losers for past month are $TDOC -14.8%, $OPRX -16.7%
- 1W winners are : Winners for past week are $DRIO 27.6%, $OPRX 8.6%
- 1W losers are : Losers for past week are $IRTC -0.2%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 32.2%, for the past 3 months is 24.6%
In the past month for a 5 days rolling window, the highest corrrelation is 78.2%, the lowest correlation is -13.7%, the latest correlation is 47.2%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 61.1% between IRTC and TDOC
The lowest correlation is 9.2% between DRIO and OPRX
The virtual care giant’s earnings were dragged by flagging growth in its BetterHelp segment, which suffered an 11% drop in paying users year over year.
Q1 2024 Teladoc Health Inc Earnings Call
Stock price doesn't tell you everything.
1Q24 revenue expected to grow over 40% year-over-year and come in between $18.5 - $19.2 million First quarter revenue and adjusted EBITDA to come in ahead of consensus DAAP adoption and cross selling activities are tracking ahead of internal expectations WALTHAM, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patie
Amidst varied financial results, Teladoc Health Inc (TDOC) outlines strategic initiatives for international expansion and enhanced platform innovations.
TDOC earnings call for the period ending March 31, 2024.
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
First Quarter Results Highlighted by Revenue Growth and Adjusted EBITDA Increase
Teladoc (TDOC) delivered earnings and revenue surprises of -4.26% and 1.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Digital medical services platform Teladoc Health (NYSE:TDOC) announced better-than-expected results in Q1 CY2024, with revenue up 2.7% year on year to $646.1 million. On the other hand, next quarter's revenue guidance of $647.5 million was less impressive, coming in 2.3% below analysts' estimates. It made a GAAP loss of $0.49 per share, down from its loss of $0.42 per share in the same quarter last year.